Societies

Carlos Torrado: Excited to present our poster at ASCO24

Photo taken from NCI CTEP Clinical Research/X

Jun 1, 2024, 12:11

Carlos Torrado: Excited to present our poster at ASCO24

Carlos Torrado, Clinical Fellow at MD Anderson Cancer Center, recently shared a post by NCI CTEP Clinical Research on X, adding:

“Excited to present our poster tomorrow at the ASCO meeting in collaboration with NCI CTEP!”

Quoting NCI CTEP Clinical Research’s post:

“ASCO24 abstract for ongoing ETCTN (10449).

Phase 1 study of BET inhibitor ZEN003694 in combination with MEK1/2 inhibitor binimetinib in solid tumors with RAS pathway alterations and triple-negative breast cancer”

Read further
Sources: Carlos Torrado/X and NCI CTEP Clinical Research/X

2024 Annual Meeting of ASCO ASCO ASCO24 binimetinib cancer Carlos Torrado ETCTN MEK1/2 inhibitor NCI CTEP Clinical Research OncoDaily Oncology RAS pathway solid tumors triple-negative breast cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage